Metsera Responds Effectively to Recent Litigation Ruling by Delaware Court
Metsera's Recent Legal Developments and Future Outlook
On November 5, 2025, Metsera, Inc. (NASDAQ: MTSR) made headlines by issuing a response to a recent litigation ruling by the Delaware Court of Chancery. This statement reflects the company's ongoing commitment to acting in the best interests of its shareholders amid legal challenges from Pfizer. The court's decision denied Pfizer's request for a temporary restraining order that could have impeded Metsera's Board of Directors from fulfilling their duties to shareholders.
Context of the Litigation
The litigation initiated by Pfizer relates to its proposed acquisition of Metsera. As part of the ongoing legal disputes, Pfizer has asserted claims that Metsera's Board is not complying with its fiduciary responsibilities. Metsera's leadership responded assertively, labeling Pfizer's litigation arguments as
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.